Proteomics Shared Resource
Proteomics Shared Resource
批准号:
9221258
负责人:
Michael A. Freitas
金额:
$13.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
3-DimensionalAbbreviationsAdoptedAlternative SplicingAwardBioinformaticsBronchoalveolar Lavage FluidCancer Center Support GrantCancer Control Research ProgramCategoriesCellsChemopreventionChromatographyComputer softwareConsultationsData AnalysesData AnalyticsData QualityData SetDissociationElectron TransportEquipmentExperimental DesignsFacultyFormalinFourier transform ion cyclotron resonanceFreezingFundingFutureGrantGroupingIonsIsotopesJournalsLeadershipMass ChromatographyMass Spectrum AnalysisMethodsMolecular BiologyMolecular CarcinogenesisNamesPeptide Sequence DeterminationPost Translational Modification AnalysisPost-Translational Protein ProcessingPreparationProtein AnalysisProtein ChemistryProteinsProteomicsProteomics Shared ResourcePublicationsResearchResearch PersonnelResource SharingRoleSalivaSamplingSerumServicesShotgunsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStructureTNFRSF5 geneTechniquesTherapeuticTissuesTrainingUnited States National Institutes of HealthWorkbasecancer geneticscancer proteomicsdata integrationdesignexperimental studyfallsimprovedinnovationinstrumentinstrumentationleukemiamass spectrometermembermetabolomicsmethod developmentoperationprogramsprotein expressionprotein protein interactionproteogenomicssenior facultytwo-dimensional
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE-013: PROTEOMICS SHARED RESOURCE (PSR)
PROJECT SUMMARY / ABSTRACT
The OSUCCC Proteomics Shared Resource (PSR) provides CCSG investigators access to advanced mass
spectrometry (MS) instrumentation, ancillary instrumentation for sample preparation, and expert staff to enable
proteomic research, including data analysis. Two tenured faculty experts in mass spectrometry and
proteomics, Drs. Michael Freitas (MBCG) and Vicki Wysocki, serve as PSR Director and Senior Faculty
Advisor, respectively. They provide scientific leadership to the PSR with expertise in cancer proteomics,
protein chemistry, bioinformatics, and mass spectroscopy methods development. The PSR offers numerous
proteomics services to users that fall under the categories of protein identification, characterization, and
quantification. The ability to confidently identify proteins is the central role of the PSR. Examples of protein
characterization analysis include: identification of post-translational modifications, alternate splice forms, de
novo protein sequencing and protein-protein interaction analysis. The Specific Aims of the PSR are to: 1)
provide advanced mass spectrometry based proteomics services; 2) provide innovative proteomic data
analytics and bioinformatics platforms; and, 3) provide consultations with investigators on experiment design
and train users on the operation of several self-operated MS instruments within the shared resource. Over the
last grant period, there have been substantial upgrades to equipment in the PSR. Early in the grant period,
three mass spectrometers were acquired with the help of federally funded awards: a Bruker Maxis Q-TOF, a
Bruker UltrafleXtreme MALDI TOF-TOF, and a Bruker AmaZon ion trap with electron transfer dissociation
(ETD). This year, three additional mass spectrometers, two high-end instruments (a Thermo Orbitrap Fusion
and a Bruker 15 T FTICR along with a Thermo Quantiva triple quadrupole for targeted (MRM) analyses) are to
be installed in the PSR with funding from two NIH S10 awards and also OSUCCC and other institutional
support. These state-of-the-art MS instruments will improve services offered to OSUCCC members by
providing significantly higher throughput shotgun proteomics, improved post-translational modification analysis,
improved isotopic fine structure analysis for metabolomics, and greater capacity and data quality. The PSR has
supported 37 OSUCCC members from all five OSUCCC research programs including 1 K24, 1 N01, 8 P01s, 2
P50s, 19 R01s, 8 R21s, 2 RC2s, 1 T32, and 2 U01s. The PSR has also contributed to over 74 OSUCCC
member publications during the last grant period, 11 of which were in publications with a journal impact factor
>10. The future plans for the PSR involve a constant effort to develop and adopt new innovative techniques
and methods for protein analysis, and to acquire state-of-the-art mass spectrometry and chromatography
instrumentation. Specifically, the PSR will fully integrate the 3 recently purchased major instruments, to
introduce methods for 2-dimensional and 3-dimensional chromatography, and provide proteogenomics data
integration. The PSR leverages extensive institutional support, and seeks only 14.2% support from CCSG
funds. The Proteomics Shared Resource is part of the Analytics Grouping.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acquisition of a Next Generation Orbitrap MS
-
批准号:8640367
-
项目类别:
-
资助金额:$57.25万
-
财政年份:2014
-
负责人:Michael A. Freitas
-
依托单位:
Identification of Histone Modification Interaction Networks
-
批准号:7570472
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2009
-
负责人:Michael A. Freitas
-
依托单位:
Identification of Histone Modification Interaction Networks
-
批准号:7897917
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2009
-
负责人:Michael A. Freitas
-
依托单位:
Acquisition of a high-throughput high mass accuracy MS for chromatin research
-
批准号:7215080
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2007
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:6941103
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:7115333
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:6762146
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8069229
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:7256926
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8268528
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8490699
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:7898985
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10553346
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10333303
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10090017
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
海外基金